Sarah Arron, PhD, MD

Dermatologic surgeon

Dr. Sarah Arron, a dermatologic surgeon, is director of the High Risk Skin Cancer Program, which cares for patients who are at risk for skin cancer due to organ transplant, leukemia, lymphoma or genetic syndromes. She specializes in an advanced procedure called Mohs micrographic surgery to treat certain types of skin cancer. Arron also is an expert in facial reconstruction following surgery, laser surgery, dermatology for organ transplant recipients and for those with genetic risk factors for skin cancer. In addition, she performs cosmetic procedures including Botox and soft tissue fillers.

Arron's research interests include studying skin cancer, particularly in patients who are immunosuppressed. She earned a medical degree at Weill Medical College of Cornell University and a doctorate at The Rockefeller University. She completed a residency in dermatology and a fellowship in Mohs micrographic surgery and procedural dermatology at UCSF. Arron is an associate professor in residence of dermatology at UCSF and the Helen Diller Family Comprehensive Cancer Center.

Clinics

Dermatologic Surgery and Laser Center
1701 Divisadero St.
San Francisco, CA 94115
Phone: (415) 353–7878
Fax: (415) 353–7838

Hours: Monday to Friday, 8 a.m. – 5 p.m.

High Risk Skin Cancer Clinic
1701 Divisadero St., Third Floor
San Francisco, CA 94143-0316
Phone: (415) 353-7878
Fax: (415) 353-9503

Hours: Friday by appointment

Melanoma and Skin Cancer Program
1600 Divisadero St., Third Floor
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday, 8 a.m. - 5 p.m.

Conditions & Treatments

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Associate Professor

More about Sarah Arron

Education

Cornell University School of Medicine 2003

Residencies

UCSF Medical Center, Dermatology 2008

Fellowships

UCSF Medical Center, Procedural Dermatology 2007

Selected Research and Publications

  1. Gao Y, Arron ST, Linos E, Polcari I, Mansh MD. Indoor Tanning, Sunless Tanning, and Sun-Protection Behaviors Among Sexual Minority Men. JAMA Dermatol. 2018 Apr 01; 154(4):477-479.
  2. Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head Neck. 2018 Mar 10.
  3. Gao Y, Arron ST, Raymond AK. Exposed hardware in a patient with invasive keratinocyte carcinoma. JAAD Case Rep. 2018 Jan; 4(1):101-103.
  4. Lai K, Harwood CA, Purdie KJ, Proby CM, Leigh IM, Ravi N, Mully TW, Brooks L, Sandoval PM, Rosenblum MD, Arron ST. Genomic analysis of atypical fibroxanthoma. PLoS One. 2017; 12(11):e0188272.
  5. Gao Y, Wei EK, Arron ST, Linos E, Margolis DJ, Mansh MD. Acne, sexual orientation, and mental health among young adults in the United States: A population-based, cross-sectional study. J Am Acad Dermatol. 2017 11; 77(5):971-973.
  6. Yuan JT, Chang TW, Yu SS, Arron ST. Mental Artery Occlusion From Poly-L-Lactic Acid Injection at the Lateral Chin. Dermatol Surg. 2017 11; 43(11):1402-1405.
  7. Harwood CA, Arron ST, Proby CM, Asgari MM, Bouwes Bavinck JN, Green AC, Toland AE. Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma. Br J Dermatol. 2017 Nov; 177(5):1150-1151.
  8. Blomberg M, He SY, Harwood C, Arron ST, Demehri S, Green A, Asgari MM. Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017 Nov; 177(5):1225-1233.
  9. Garrett GL, Yuan JT, Shin TM, Arron ST. Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study. J Am Acad Dermatol. 2018 Feb; 78(2):264-269.
  10. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
  11. Wei L, Allain DC, Bernhardt MN, Gillespie JL, Peters SB, Iwenofu OH, Nelson HH, Arron ST, Toland AE. Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs. Br J Dermatol. 2017 Oct; 177(4):1066-1073.
  12. Yuan JT, Tello TL, Hultman C, Barker CA, Arron ST, Yom SS. Medical marijuana for the treatment of vismodegib-related muscle spasm. JAAD Case Rep. 2017 Sep; 3(5):438-440.
  13. Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. J Am Acad Dermatol. 2017 Oct; 77(4):713-718.
  14. Charruyer A, Fong S, Vitcov GG, Sklar S, Tabernik L, Taneja M, Caputo M, Soeung C, Yue L, Uchida Y, Arron ST, Horton KM, Foster RD, Sano S, North JP, Ghadially R. Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation. Stem Cells. 2017 Aug; 35(8):2001-2007.
  15. Ahn RS, Taravati K, Lai K, Lee KM, Nititham J, Gupta R, Chang DS, Arron ST, Rosenblum M, Liao W. Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin. Sci Rep. 2017 05 02; 7(1):1343.
  16. Yanik EL, Pfeiffer RM, Freedman DM, Weinstock MA, Cahoon EK, Arron ST, Chaloux M, Connolly MK, Nagarajan P, Engels EA. Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiol Biomarkers Prev. 2017 Jul; 26(7):998-1007.
  17. Hibler BP, Saylor DK, Chin-Hong P, Arron ST. Antimicrobial Prophylaxis for Full-Face Laser Resurfacing in Transplant Recipients. Dermatol Surg. 2017 04; 43(4):599-604.
  18. Stuart SE, Schoen P, Jin C, Parvataneni R, Arron S, Linos E, Boscardin WJ, Chren MM. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. J Am Acad Dermatol. 2017 Jun; 76(6):1131-1138.e1.
  19. Dizon MP, Linos E, Arron ST, Hills NK, Chren MM. Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures. PLoS One. 2017; 12(1):e0171253.
  20. Mansh M, Ing L, Dimon M, Celli A, Mauro TM, Arron ST. Voriconazole exposure regulates distinct cell-cycle and terminal differentiation pathways in primary human keratinocytes. Br J Dermatol. 2017 03; 176(3):816-820.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.